SCHEDULE 13D/A

Beneficial Ownership Report

COSCIENS Biopharma Inc. Filed 2024-12-20 Acc 0001493152-24-051131

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-06-11 SCHEDULE 13D/A Beneficial Ownership Report
2024-12-23 6-K Report of Foreign Issuer
2024-12-20 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

External

SEC EDGAR (opens in new tab)